Clinical trial
Evaluation and Treatment of Eye Complications of Vaccinia Vaccination
NCT00081835 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00081835 |
|---|---|
| Title | Evaluation and Treatment of Eye Complications of Vaccinia Vaccination |
| Official title | Evaluation and Treatment of Ocular Complications of Vaccinia Vaccination: Suitability of NP-016 Vaccinia Immune Globulin (VIG) for Sight-Threatening Conditions [VIG31] |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vaccinia |
| Intervention type | Drug |
| Interventions | NP-016 Vaccine Immune Globulin (IV-VIG) |
| Enrollment | 400 |
| Start date | Apr 19, 2004 |
| Completion | Aug 15, 2007 |
| First posted | Apr 22, 2004 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: